Icure Acquires Drug Product Approval For World’s First Donepezil Patch For Treating Dementia Of The Alzheimer Type In Korea
· The world’s first donepezil patch is approved for the incrementally modified drug· Launching in 2022, its availability will be expanded to the global market SEOUL, South Korea, Nov 17 (Bernama-BUSINESS WIRE) — Icure Pharmaceutical Inc. (KOSDAQ: 175250), a biopharmaceutical company in Korea, announced today that its donepezil patch, a treatment of…

